Emergex Vaccines

0 followers

Emergex, a clinical-stage, privately-held biotechnology company headquartered in Abingdon, UK, with an operating subsidiary in Doylestown, Pennsylvania, USA, is pioneering the development of 100% synthetic T cell-priming immune set-point vaccine candidates that harness and direct the body’s natural... Read more

Industries

Employees

11-50

Links


Org chart

Thomas Rademacher
Founder And CEO
Collapse
Brian Pfister
Vice President
Natalie Sands Fcca
Head Of Finance
László Fekete
Quality Director

Teams

This company has no teams yet